Skip to main content
SpringerLink
Log in

Rectal Cancer

  • Chapter
  • First Online:
Surgical Oncology Manual

  • 823 Accesses

Abstract

Rectal cancer is one of the leading causes of cancer mortality in both men and women worldwide. Multimodal management with chemotherapy, radiotherapy, and surgical resection remain the mainstay in rectal cancer treatment. The optimal use and timing of these treatment modalities are evolving. Ongoing research on “watch-and-wait,” total neoadjuvant therapy, transanal minimally invasive surgery including transanal total mesorectal excision, lateral lymph node dissection, and the use of MRI to predict utility of neoadjuvant chemoradiation is advancing the ways rectal cancer is treated. Advances in systemic and targeted therapies have helped improve survival in patients with both local and distant disease. Given the progression of treatment options, discussion of all rectal cancer patients in a multidisciplinary forum is essential to optimize outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Canadian Cancer Society, Statistics Canada. Canadian Cancer Statistics 2017.

    Google Scholar 

  2. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1–8.

    Article  PubMed  Google Scholar 

  3. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2015, National Cancer Institute. Bethesda, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

  4. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303.

    Article  PubMed  Google Scholar 

  5. Members of the Colorectal Cancer Survivorship Group. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer. Toronto: Cancer Care Ontario; 2012 Feb 3 [Being Updated 2018 Jun]. Program in Evidence-based Care Evidence-Based Series No.: 26-2 Version 2. Being updated.

    Google Scholar 

  6. Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology. 2004;232(3):773.

    Article  PubMed  Google Scholar 

  7. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19(7):2212–23.

    Article  PubMed  Google Scholar 

  8. Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh B, Kapoor R, et al. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level. Nucl Med Commun. 2011;32(9):789–93.

    Article  PubMed  Google Scholar 

  9. National Comprehensive Cancer Network. Rectal Cancer (Version 2.2019). https://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf. Accessed 4 June 2019.

  10. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, Pas MHVD, Klerk ESDL-D, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372(14):1324–32.

    Article  CAS  PubMed  Google Scholar 

  11. Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomized controlled trial. Lancet Oncol. 2014;15(7):767–74.

    Article  PubMed  Google Scholar 

  12. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74–82.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nagtegaal D, van de Velde C, Marijnen CAM, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.

    Article  PubMed  Google Scholar 

  14. Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs abdominoperineal resection. Dis Colon Rectum. 2004;47:48–58.

    Article  PubMed  Google Scholar 

  15. Han JG, Wang ZJ, Wei GH, et al. Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer. Am J Surg. 2012;204(3):274–82.

    Article  PubMed  Google Scholar 

  16. West NP, Finan PJ, Anderin C, et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26(21):3517.

    Article  PubMed  Google Scholar 

  17. Persiani R, Biondi A, Gambacorta MA, et al. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer. Br J Surg. 2014;101(2):133–42.

    Article  CAS  PubMed  Google Scholar 

  18. Awwad GE, Tou SI, Rieger NA. Prognostic signifi cance of lymph node yield after long-course preoperative radiotherapy in patients with rectal cancer: a systematic review. Color Dis. 2013;15(4):394–403.

    Article  CAS  Google Scholar 

  19. Miller ED, Robb BW, Cummings OW, et al. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon Rectum. 2012;55(9):1002–7.

    Article  PubMed  Google Scholar 

  20. Fokas E, Liersch T, Fietkau R, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol. 2014;32(15):1554.

    Article  PubMed  Google Scholar 

  21. Protocol for the examination of specimens from patients with primary carcinoma of the colon (Version Colon Rectum 4.0.1.0). https://documents.cap.org/protocols/cp-gilower-colonrectum-17protocol-4010.pdf. Protocol web posting date: June 2017. Accessed 4 June 2019.

  22. Patel UBP, Taylor F, Blomqvist L, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29(28):3753–60.

    Article  PubMed  Google Scholar 

  23. Heidary B, Phang TP, Raval MJ, et al. Transanal endoscopic microsurgery: a review. Can J Surg. 2014;57(2):127–38.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bouvet M, Milas M, Giacco GG, et al. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol. 1999;6:26–32.

    Article  CAS  PubMed  Google Scholar 

  25. Hahnloser D, Wolff BG, Larson DW, et al. Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum. 2005;48:429–37.

    Article  PubMed  Google Scholar 

  26. Levic K, Bulut O, Hesselfeldt P, et al. The outcome of rectal cancer after early salvage TME following TEM compared with primary TME: a case-matched study. Tech Coloproctol. 2013;17(4):397–403.

    Article  CAS  PubMed  Google Scholar 

  27. Bujko K, Richter P, Kolodziejczyk M, et al. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol. 2009;92(2):195–201.

    Article  PubMed  Google Scholar 

  28. Habr-Gama A, Sao Juliao GP, Perez RO. Pitfalls of transanal endoscopic microsurgery for rectal cancer following neoadjuvant chemoradiation therapy. Minim Invasive Ther. 2014;23(2):63–9.

    Article  Google Scholar 

  29. Guerrieri M, Baldarelli M, Rimini M, et al. Transanal endoscopic microsurgery for rectal tumors: an option to radical surgery? Minerva Chir. 2013;68(3):289–98.

    CAS  PubMed  Google Scholar 

  30. Perez RO, Habr-Gama A, Lynn PB, et al. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Dis Colon Rectum. 2013;56(1):6–13.

    Article  PubMed  Google Scholar 

  31. Pucciarelli S, De Paoli A, Guerrieri M, et al. Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum. 2013;56(12):1349–56.

    Article  PubMed  Google Scholar 

  32. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in local recurrence of rectal cancer. Lancet. 1994;344:707–11.

    Article  CAS  PubMed  Google Scholar 

  33. Fitzgerald TL, Brinkley J, Zervos EE. Pushing the envelope beyond a centimeter in rectal cancer: oncologic implications of close, but negative margins. J Am Coll Surg. 2011;213(5):589–95.

    Article  PubMed  Google Scholar 

  34. Nagtegaal ID, Gosens MJ, Marijnen CA, et al. Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol. 2007;25:1647–50.

    Article  PubMed  Google Scholar 

  35. Swedish Rectal Cancer Trial, Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997;336(14):980–7.

    Article  Google Scholar 

  36. Folkesson J, Birgisson H, Pahlman L, et al. Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23(24):5644–50.

    Article  PubMed  Google Scholar 

  37. Taylor FGM, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone. Ann Surg. 2011;253(4):711–9.

    Article  PubMed  Google Scholar 

  38. Taylor FGM, Quirke P, Heald RJ, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32(1):34–43.

    Article  PubMed  Google Scholar 

  39. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.

    Article  CAS  PubMed  Google Scholar 

  40. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926–33.

    Article  CAS  PubMed  Google Scholar 

  41. Roh MS, Colangelo LH, O’Connell MJ. Preoperative multimodality therapy improves disease free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27(31):5124–30.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–23.

    Article  CAS  PubMed  Google Scholar 

  43. Ngan S, Fisher R, Goldstein D, et al. A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: an intergroup trial (TROG, AGITG, CSSANZ, RACS). J Clin Oncol. 2010;28:15s.

    Article  Google Scholar 

  44. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. EORTC Radiotherapy Group Trial 22921. N Engl J Med. 2006;355(11):1114.

    Article  CAS  PubMed  Google Scholar 

  45. McCarthy K, Pearson K, Fulton R, et al. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst Rev. 2012;12:CD008368.

    PubMed  Google Scholar 

  46. Callender GG, Das P, Rodriguez-Bigas MA, et al. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010;17(2):441.

    Article  PubMed  Google Scholar 

  47. Borschitz T, Wachtlin D, Möhler M, et al. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol. 2008;15(3):712.

    Article  PubMed  Google Scholar 

  48. Faneyte IF, Dresen RC, Edelbrok MA, et al. Preoperative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer. Dig Surg. 2008;25:202–7.

    Article  PubMed  Google Scholar 

  49. Das P, Delclos ME, Skibber JM, et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior irradiation. Int J Radiat Oncol Biol Phys. 2010;77:60–5.

    Article  PubMed  Google Scholar 

  50. Hyngstrom JR, Tzeng CW, Beddar S, et al. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014;109(7):652–8.

    Article  PubMed  Google Scholar 

  51. Lehnert T, Methner M, Pollok A, et al. Multivisceral resection for locally advanced primary colon and rectal cancer. An analysis of prognostic factors in 201 patients. Anal Surg. 2002;235:217–35.

    Article  Google Scholar 

  52. Bhangu A, Ali SM, Darzi A, et al. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Color Dis. 2012;14(12):1457–66.

    Article  CAS  Google Scholar 

  53. Rodriguez-Bigas M, Chang C, Skibber J. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am. 2010;19:847–59.

    Article  PubMed  Google Scholar 

  54. Sridharan M, Hubbard JM, Grothey A. Colorectal cancer: how emerging molecular understanding affects treatment decisions. Oncology. 2014;28(2):110–8.

    PubMed  Google Scholar 

  55. Culverwell AD, Chowdhury FU, Scarsbrook AF. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer. Abdom Imaging. 2012;37(6):1021–31.

    Article  CAS  PubMed  Google Scholar 

  56. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fl uorodeoxyglucose (FDG-PET). Ann Surg. 2004;240(3):438–47.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kanzaki R, Higashiyama M, Oda K, et al. Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. Am J Surg. 2011;202(4):419–26.

    Article  PubMed  Google Scholar 

  60. Blackmon SH, Stephens EH, Correa AM, et al. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg. 2012;94(6):1802.

    Article  PubMed  Google Scholar 

  61. Iida T, Nomori H, Shiba M, Metastatic Lung Tumor Study Group of Japan, et al. Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysis. Ann Surg. 2013;257(6):1059.

    Article  PubMed  Google Scholar 

  62. Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24(24):4011.

    Article  PubMed  Google Scholar 

  63. Lemke J, Scheele J, Kapapa T, et al. Brain metastases in gastrointestinal cancers: is there a role for surgery? Int J Mol Sci. 2014;15(9):16816–30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379–84.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Tarantino I, Warschkow R, Worni M, et al. Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients. Ann Surg. 2015;262(1):112–20.

    Article  PubMed  Google Scholar 

  66. Rahbari NN, Lordick F, Fink C, et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS – a randomized controlled multicenter trial (ISRCTN30964555). BMC Cancer. 2012;12:142.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg. 1982;69:613–6.

    Article  CAS  PubMed  Google Scholar 

  68. Kapiteijn E, Marijen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.

    Article  CAS  PubMed  Google Scholar 

  69. Tan WS, Tang CL, Shi L, et al. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009;96(5):462–72.

    Article  CAS  PubMed  Google Scholar 

  70. Frykholm GJ, Glimelius B, Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum. Dis Colon Rectum. 1993;36(6):564–72.

    Article  CAS  PubMed  Google Scholar 

  71. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol. 1992;10(8):1218–24.

    Article  CAS  PubMed  Google Scholar 

  72. Kennedy E, Vella ET, MacDonald DB, Wong CS, McLeod R. Optimisation of preoperative assessment in patients diagnosed with rectal cancer. Clin Oncol. 2015;27(4):225–45.

    Article  CAS  Google Scholar 

  73. Snyder RA, Hu C-Y, Cuddy A, Francescatti AB, Schumacher JR, Loon KV, et al. Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA. 2018;319(20):2104.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Wille-Jørgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, et al. Effect of more vs less frequent follow-up testing on overall and colorectal cancer–specific mortality in patients with stage II or III colorectal cancer. JAMA. 2018;319(20):2095.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Clinical Outcomes of Surgical Therapy Study Group, Nelson H, Sargent DJ, Wieand HS, Fleshman J, Anvari M, Stryker SJ, Beart RW Jr, Hellinger M, Richard Flanagan WP Jr, Ota D. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350(20):2050–9.

    Article  Google Scholar 

  76. Kennedy ED, Simunovic M, Jhaveri K, Kirsch R, Brierley J, Drolet S, et al. Safety and feasibility of using magnetic resonance imaging criteria to identify patients with “good prognosis” rectal cancer eligible for primary surgery. JAMA Oncol. 2019;5(7):961–6.

    Google Scholar 

  77. Bosset J-F, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun R-J, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 2014;15(2):184–90.

    Article  CAS  PubMed  Google Scholar 

  78. Cercek A, Roxburgh CS, Strombom P, Smith JJ, Temple LK, Nash GM, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4(6):e180071.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Fernandez-Martos C, Garcia-Albeniz X, Pericay C, Maurel J, Aparicio J, Montagut C, et al. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol. 2015;26(8):1722–8.

    Article  CAS  PubMed  Google Scholar 

  80. Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L, et al. Modified FOLFOX6 with or without radiation in neoadjuvant treatment of locally advanced rectal cancer: final results of the Chinese FOWARC multicenter randomized trial. J Clin Oncol. 2018;36(15_suppl):3502.

    Article  Google Scholar 

  81. Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Schrag D. Alliance for clinical trials in oncology. 2012 January. PROSPECT: Chemotherapy alone or chemotherapy plus radiation therapy in treating patients with locally advanced rectal cancer undergoing surgery. (ClinicalTrials.gov Identifier NCT0151578). Retrieved from: https://clinicaltrials.gov/ct2/show/NCT01515787#moreinfo.

  83. Petrelli F, Sgroi G, Sarti E, Barni S. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer. Ann Surg. 2016;263(3):458–64.

    Article  PubMed  Google Scholar 

  84. Du D, Su Z, Wang D, Liu W, Wei Z. Optimal interval to surgery after neoadjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer. 2018;17(1):13–24.

    Article  PubMed  Google Scholar 

  85. Erlandsson J, Holm T, Pettersson D, Berglund Å, Cedermark B, Radu C, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017;18(3):336–46.

    Article  PubMed  Google Scholar 

  86. Lefevre JH, Mineur L, Kotti S, Rullier E, Rouanet P, Chaisemartin CD, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol. 2016;34(31):3773–80.

    Article  PubMed  Google Scholar 

  87. Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(7):501–13.

    Article  PubMed  Google Scholar 

  88. Smith JJ, Strombom P, Chow OS, Roxburgh CS, Lynn P, Eaton A, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5(4):e185896.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174–83.

    Article  PubMed  Google Scholar 

  90. Van Der Valk MJM, Hilling DE, Bastiaannet E, Kranenbarg EM-K, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–45.

    Article  PubMed  Google Scholar 

  91. Kennedy E. Mount Sinai Hospital, Canada. 2017 June. Non-operative management for locally advanced rectal cancer (NOM). (ClinicalTrials.gov Identifier NCT03179540). Retrieved from: https://clinicaltrials.gov/ct2/show/record/NCT03179540?view=record.

  92. Stevenson ARL, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer. JAMA. 2015;314(13):1356.

    Article  CAS  PubMed  Google Scholar 

  93. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes. JAMA. 2015;314(13):1346.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Stevenson ARL, Solomon MJ, Brown CSB, Lumley JW, Hewett P, Clouston AD, et al. Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer. Ann Surg. 2019;269(4):596–602.

    Article  PubMed  Google Scholar 

  95. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer. Ann Surg. 2019;269(4):589–95.

    Article  PubMed  Google Scholar 

  96. Acuna SA, Chesney TR, Ramjist JK, Shah PS, Kennedy ED, Baxter NN. Laparoscopic versus open resection for rectal cancer. Ann Surg. 2019;269(5):849–55.

    Article  PubMed  Google Scholar 

  97. Adamina M, Buchs NC, Penna M, Hompes R. St.Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc. 2017;32(3):1091–103.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Motson RW, Whiteford MH, Hompes R, Albert M, Miles WFA. Current status of trans-anal total mesorectal excision (TaTME) following the second international consensus conference. Color Dis. 2016;18(1):13–8.

    Article  CAS  Google Scholar 

  99. Deijen CL, Velthuis S, Tsai A, Mavroveli S, ESM De Lange-De Klerk, Sietses C, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2015;30(8):3210–3215.

    Google Scholar 

  100. Vignali A, Elmore U, Milone M, Rosati R. Transanal total mesorectal excision (TaTME): current status and future perspectives. Updat Surg. 2019;71(1):29–37.

    Article  Google Scholar 

  101. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision. Ann Surg. 2019;269(4):700–11.

    Article  PubMed  Google Scholar 

  102. Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Color Dis. 2016;18(1):19–36.

    Article  CAS  Google Scholar 

  103. Lacy FBD, Jacqueline J, Van Laarhoven EM, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, et al. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc. 2017;32(5):2442–7.

    Article  PubMed  Google Scholar 

  104. Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol. 2019;37(1):33–43.

    Article  CAS  PubMed  Google Scholar 

  105. Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212). Ann Surg. 2017;266(2):201–7.

    Article  PubMed  Google Scholar 

  106. Issa N, Murninkas A, Powsner E, Dreznick Z. Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer. World J Surg. 2012;36(10):2481–7.

    Article  PubMed  Google Scholar 

  107. Debove C, Guedj N, Tribillon E, Maggiori L, Zappa M, Panis Y. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response? Int J Color Dis. 2016;31(4):853–60.

    Article  Google Scholar 

  108. Barina A, Paoli AD, Delrio P, Guerrieri M, Muratore A, Bianco F, et al. Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study. Tech Coloproctol. 2017;21(8):633–40.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Surgical Oncology, University of Toronto, Toronto, ON, Canada

    Ricky Jrearz

  2. Department of Surgery, University of Toronto, Toronto, ON, Canada

    Shady Ashamalla, Marcus J. Burnstein, Erin Kennedy & Peter K. Stotland

  3. Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada

    William Chu

Authors
  1. Ricky Jrearz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shady Ashamalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcus J. Burnstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erin Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter K. Stotland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter K. Stotland .

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Toronto, Toronto, ON, Canada

    Frances C. Wright

  2. Department of Surgery, University of Toronto, Toronto, ON, Canada

    Jaime M. Escallon

  3. Department of Surgery, University of Toronto, Toronto, ON, Canada

    Moises Cukier

  4. Department of Surgery, University of Toronto, Toronto, ON, Canada

    Melanie E. Tsang

  5. Department of Surgery, University of Toronto, Toronto, ON, Canada

    Usmaan Hameed

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jrearz, R., Ashamalla, S., Burnstein, M.J., Chu, W., Kennedy, E., Stotland, P.K. (2020). Rectal Cancer. In: Wright, F., Escallon, J., Cukier, M., Tsang, M., Hameed, U. (eds) Surgical Oncology Manual. Springer, Cham. https://doi.org/10.1007/978-3-030-48363-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48363-0_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48362-3

  • Online ISBN: 978-3-030-48363-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation